Detalhe da pesquisa
1.
Early Treatment with Pegylated Interferon Lambda for Covid-19.
N Engl J Med
; 388(6): 518-528, 2023 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36780676
2.
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy.
J Immunol
; 212(6): 1002-1011, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38294274
3.
Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus.
Proc Natl Acad Sci U S A
; 120(24): e2220294120, 2023 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37276424
4.
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries.
Hepatology
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38478751
5.
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN trials.
Hepatology
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630448
6.
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.
Am J Transplant
; 24(3): 468-478, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37871798
7.
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
J Hepatol
; 80(5): 730-743, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38199298
8.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38483300
9.
Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus.
J Viral Hepat
; 2024 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38326950
10.
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
J Viral Hepat
; 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38619214
11.
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
J Viral Hepat
; 31(4): 197-207, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38243144
12.
Pathway to global elimination of hepatitis B: HBV cure is just the first step.
Hepatology
; 78(3): 976-990, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37125643
13.
Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.
Hepatology
; 78(5): 1525-1541, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37158243
14.
Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis.
Liver Int
; 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38563728
15.
Maternal neighbourhood-level social determinants of health and their association with paediatric hepatitis C screening among children exposed to hepatitis C in pregnancy.
Paediatr Perinat Epidemiol
; 38(2): 152-160, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38273801
16.
Evaluation of Prenatal Hepatitis C Virus Prevalence Using Universal Screening, and Linkage to Care in a Real-World Setting in Ontario.
J Obstet Gynaecol Can
; 46(6): 102423, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38452927
17.
What is needed to move toward single-step diagnosis of current HCV infection?
J Infect Dis
; 2023 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37831406
18.
Ethics of Controlled Human Infection Studies With Hepatitis C Virus.
Clin Infect Dis
; 77(Suppl 3): S216-S223, 2023 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37579202
19.
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.
Clin Infect Dis
; 77(Suppl 3): S231-S237, 2023 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37579207
20.
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
Clin Infect Dis
; 77(Suppl 3): S262-S269, 2023 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37579209